Pfizer Inc. (PFE) Q3 2017 Earnings Results

Pfizer Beats on EPS, Stock Down 0.26%

Pfizer's earnings report showed a slight beat on EPS, which may indicate better-than-expected profitability. However, the stock reacted negatively, declining by 0.26%. This could suggest investor concerns about future revenue growth or lack of guidance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.67	N/A	+1.14%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management expressed a positive outlook on their product pipeline. However, they did not provide specific guidance for the upcoming quarters.

Management highlighted ongoing developments in their pipeline.

They emphasized the importance of innovation in driving future growth.

Pfizer Beats on EPS, Stock Down 0.26%

Key numbers

Management commentary

Pfizer Inc.

More earnings this week

Pfizer Beats on EPS, Stock Down 0.26%

Key numbers

Management commentary